Sign in

DMP on Frankfurt Stock Exchange

Dermapharm

German pharmaceutical company

Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations.2 It employed 3,497 people in 2023.1 Its revenue was €1.1 billion in 2023.1 Its shares trade on Frankfurt Stock Exchange under the symbol DMP.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1991Founded1

Compare with another stock.

  • TickerDMP on Frankfurt Stock Exchange1
  • Industrypharmaceutical company1
  • HeadquartersGrünwald1
  • Websitewww.dermapharm.de
  • Legal formAktiengesellschaft1
  • LEI5299009F0KNZINQQQK373
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressLil-Dagover-Ring 7, 82031 Grünwald, Germany3
  • Registered withLocal Court München, HRB 2345753

See how the biggest companies compare on our leaderboards

Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations.2

Corporate structure

Dermapharm is part of a group headed by Themis Beteiligungs-Aktiengesellschaft. 10 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Themis Beteiligungs-Aktiengesellschaft Grünwald, Germany
    • Dermapharm Grünwald, Germany
      • Allergopharma AG Subsidiary · Hünenberg, Switzerland
      • Dermapharm AG Subsidiary · Hünenberg, Switzerland
        • EUROMED S.A. (SOCIEDAD UNIPERSONAL) Subsidiary · Mollet del Vallès, Spain
      • Dermapharm Aktiengesellschaft Subsidiary · Grünwald, Germany
        • Aktiebolaget Cernelle. Subsidiary · 100% · Ängelholm, Sweden
      • mibe GmbH Arzneimittel Subsidiary · Brehna, Germany
      • Strathmann GmbH & Co. KG Subsidiary · Hamburg, Germany
    • Allergopharma GmbH & Co. KG Subsidiary · Reinbek, Germany

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

Leadership

Who has led Dermapharm, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (1)

Subsidiaries and ownership

Parent company (GLEIF)

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Employees over time

Dermapharm employees by year13.5K in 2023+216% since 2014
01.0K2.0K3.0K4.0K2014: 1.1K1.1K20142015: 1.1K1.1K2015−1%2016: 1.1K1.1K2016+2%2017: 1.2K1.2K2017+12%2018: 1.6K1.6K2018+31%2019: 1.9K1.9K2019+14%2020: 2.3K2.3K2020+25%2021: 2.4K2.4K2021+3%2022: 2.6K2.6K2022+8%2023: 3.5K3.5K2023+36%
  • 20233,4971
  • 20222,5631
  • 20212,3731
  • 20202,3111
  • 20191,8531
  • 20181,6191
  • 20171,2401
  • 20161,1121

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

Dermapharm revenue by year11.1B EUR in 2023+190% since 2014
0500.0M EUR1.0B EUR1.5B EUR2014: 391.3M EUR391.3M EUR20142015: 384.8M EUR384.8M EUR2015−2%2016: 444.5M EUR444.5M EUR2016+15%2017: 467.1M EUR467.1M EUR2017+5%2018: 572.4M EUR572.4M EUR2018+23%2019: 700.9M EUR700.9M EUR2019+22%2020: 793.8M EUR793.8M EUR2020+13%2021: 942.9M EUR942.9M EUR2021+19%2022: 1.0B EUR1.0B EUR2022+9%2023: 1.1B EUR1.1B EUR2023+11%
  • 20231.1B EUR1
  • 20221.0B EUR1
  • 2021942.9M EUR1
  • 2020793.8M EUR1
  • 2019700.9M EUR1
  • 2018572.4M EUR1

Net income

Dermapharm net income by year1131.4M EUR in 2025
-100.0M EUR0100.0M EUR200.0M EUR300.0M EUR2014: -2.0M EUR-2.0M EUR20142015: 14.7M EUR14.7M EUR20152016: 15.8M EUR15.8M EUR2016+8%2017: 20.6M EUR20.6M EUR2017+30%2018: 75.2M EUR75.2M EUR2018+265%2019: 77.8M EUR77.8M EUR2019+3%2020: 85.9M EUR85.9M EUR2020+10%2021: 208.9M EUR208.9M EUR2021+143%2022: 134.2M EUR134.2M EUR2022−36%2025: 131.4M EUR131.4M EUR2025−2%
  • 2025131.4M EUR1
  • 2022134.2M EUR1
  • 2021208.9M EUR1
  • 202085.9M EUR1
  • 201977.8M EUR1
  • 201875.2M EUR1

Timeline

  1. Feb 21, 2024Parent Directly consolidated by Themis Beteiligungs-Aktiengesellschaft3
  2. Feb 9, 2018Went public Listed on Frankfurt Stock Exchange1
  3. 1991Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3